Wells Fargo & Company Gritstone Bio, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 29,252 shares of GRTS stock, worth $6,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,252

Previous 143,100 79.56%

Holding current value

$6,435

Previous $367,000 95.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.62 - $2.35 $7,344 - $27,838	-11,846 Reduced 28.82%	29,252 $18,000
Q1 2024 May 10, 2024	SELL	$1.96 - $2.9 $5,280 - $7,812	-2,694 Reduced 6.15%	41,098 $105,000
Q4 2023 Feb 09, 2024	BUY	$1.28 - $2.85 $22,766 - $50,690	17,786 Added 68.39%	43,792 $89,000
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.26 $22,599 - $42,919	-18,991 Reduced 42.21%	26,006 $44,000
Q2 2023 Aug 15, 2023	BUY	$1.66 - $3.03 $54,660 - $99,771	32,928 Added 272.83%	44,997 $87,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.74 $17 - $29	8 Added 0.07%	12,069 $33,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $162 - $294	75 Added 0.63%	12,061 $41,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.75 $100 - $194	41 Added 0.34%	11,986 $31,000
Q2 2022 Aug 12, 2022	SELL	$1.77 - $4.34 $120,885 - $296,408	-68,297 Reduced 85.11%	11,945 $29,000
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $203,325 - $615,022	-50,453 Reduced 38.6%	80,242 $331,000
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $774,042 - $1.21 Million	-88,361 Reduced 40.34%	130,695 $1.68 Million
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $1.22 Million - $2.57 Million	190,039 Added 654.92%	219,056 $2.37 Million
Q2 2021 Aug 16, 2021	SELL	$8.13 - $10.2 $58,267 - $73,103	-7,167 Reduced 19.81%	29,017 $265,000
Q1 2021 May 13, 2021	BUY	$4.07 - $27.11 $12,787 - $85,179	3,142 Added 9.51%	36,184 $341,000
Q4 2020 Feb 09, 2021	BUY	$2.57 - $4.22 $38,686 - $63,523	15,053 Added 83.68%	33,042 $130,000
Q3 2020 Nov 05, 2020	SELL	$2.63 - $8.09 $15,369 - $47,277	-5,844 Reduced 24.52%	17,989 $48,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $8.17 $19,198 - $27,565	-3,374 Reduced 12.4%	23,833 $158,000
Q1 2020 May 14, 2020	BUY	$5.47 - $11.3 $148,822 - $307,439	27,207 New	27,207 $158,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $16.1M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Gritstone Bio, Inc. Transaction History